-
RSL3: A GPX4 Inhibitor for Ferroptosis Assays
2026-08-25
Explore how RSL3, a glutathione peroxidase 4 inhibitor, converts redox vulnerability into a rigorously testable ferroptosis phenotype. This article connects GPX4 perturbation with TEAD2 biology, RAS-driven models, and evidence-based assay design.
-
Fenofibrate Workflows for PPARα-YAP Research
2026-08-24
Build reproducible Fenofibrate assays around PPARα engagement, lipid metabolism, and downstream YAP signaling rather than relying on viability readouts alone. This guide connects stock preparation, time-resolved cell workflows, liver enlargement models, and cancer assays with practical troubleshooting for stronger mechanistic interpretation.
-
Ibrexafungerp (MK 3118): Evidence & Workflows
2026-08-24
Ibrexafungerp, also known as MK 3118 or SCY-078, is an oral triterpenoid glucan synthase inhibitor with activity against several resistant Candida phenotypes. Clinical approval covers vulvovaginal candidiasis and reduction of recurrent vulvovaginal candidiasis, while invasive candidiasis remains an investigational application.
-
Graphene FIR and Apoptosis in Melanoma
2026-08-23
The reference study shows that graphene-mediated far-infrared radiation suppresses malignant melanoma through coordinated apoptosis induction, G0/G1 cell-cycle arrest, altered hypoxia-associated signaling, and tumor-growth inhibition. Caspase-inhibitor rescue experiments further implicate caspase-9 and caspase-3 as functional components of the response, providing a rationale for pathway-focused follow-up studies.
-
Mithramycin A: From G-C DNA to Translational Insight
2026-08-22
A thought-leadership guide to using Mithramycin A as a mechanistic transcriptional probe, linking G-C-rich DNA binding and c-myc biology with the miR-24-3p/Sp1/PI3K findings in doxorubicin-induced cardiac injury.
-
Captopril Workflows for ACE and Bradykinin Research
2026-08-22
Captopril provides a practical way to connect ACE inhibition in hypertension research with functional studies of bradykinin-dependent intestinal motility. This guide translates its biochemical profile into reproducible enzyme, organ-bath, and oncology workflows, with controls that help separate upstream ACE effects from direct receptor signaling.
-
Z-VAD-FMK Workflow for Apoptosis Research
2026-08-21
Z-VAD-FMK provides a practical causal test for caspase-dependent cell death, from APL models to immune-cell assays. This workflow combines inhibitor timing, orthogonal apoptosis readouts, and stock-handling controls to distinguish true apoptosis inhibition from assay artifacts.
-
Exogenous NADH Potentiates Aminoglycosides in E. tarda
2026-08-20
The 2024 Virulence study shows that exogenous NADH can reprogram Edwardsiella tarda metabolism, increase ATP availability, and strengthen neomycin-mediated bacterial killing. Its broader contribution is a metabolism-based antibiotic-potentiation strategy that was also examined with other antibiotic classes and resistant bacterial models.
-
Biotin-16-UTP for RNA Labeling Workflows
2026-08-20
Biotin-16-UTP converts in vitro transcribed RNA into an affinity reagent for streptavidin-based detection, capture, and interaction assays. This practical guide connects reproducible RNA workflows with the reference study’s allosteric fluorogenic aptamer strategy, clarifying when biochemical labeling complements live-cell protein tracking.
-
Oteseconazole (VT-1161) Research Workflows
2026-08-19
Build more reproducible Candida susceptibility assays with Oteseconazole (VT-1161), a selective fungal CYP51 inhibitor suited to species panels, resistant isolates, and mechanism-focused studies. This guide connects compound handling, MIC testing, orthogonal validation, and troubleshooting to practical antifungal research use-cases.
-
Boc-D-FMK: From Caspase Control to Translation
2026-08-19
Boc-D-FMK offers translational researchers a practical way to test whether caspase activity links TNF-driven apoptosis with inflammatory and tissue-remodeling phenotypes. This thought-leadership perspective connects mechanistic validation, model selection, workflow design, and fibrosis-oriented research while defining the compound’s limits as a broad-spectrum probe.
-
Five-Element Nanoparticles for Lung mRNA Delivery
2026-08-18
Cao and colleagues developed five-element nanoparticles that combine poly(β-amino esters) with DOTAP to improve both lung-specific mRNA delivery and formulation stability. The study links polymer structure, nanoparticle interactions, protein-corona-mediated targeting, and lyophilization to a delivery platform reported to remain stable under refrigerated storage.
-
Palomid 529: A Mechanism-to-Assay Roadmap
2026-08-18
Palomid 529 (P529) offers a translational way to test whether PI3K/Akt/mTOR pathway dependence contributes to ESCC metastasis and cisplatin resistance. This article converts the RCN2–PPP2CA–PI3K-AKT discovery into a rigorous assay strategy while separating established evidence from forward-looking experimental hypotheses.
-
Amorolfine Hydrochloride in Yeast Ploidy Assays
2026-08-17
Use Amorolfine Hydrochloride to connect membrane-synthesis stress with the ploidy limits of budding yeast. This workflow pairs growth, cell-surface integrity, DNA-content, and expression readouts to distinguish direct antifungal effects from secondary cell-cycle consequences.
-
RSL3 and GPX4: A Decision Framework for Ferroptosis
2026-08-17
RSL3 is a selective glutathione peroxidase 4 inhibitor for experimentally dissecting ferroptosis, redox collapse, and tumor-cell vulnerability. This guide connects RSL3 assay design with TEAD2 biology in hepatocellular carcinoma, emphasizing how to distinguish ferroptotic causality from nonspecific cytotoxicity.